{"schema_version":"secwatch.filing_event.v1","accession":"0001448431-26-000014","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2026-08-12T20:07:41+00:00","discovered_at":"2026-08-12T20:09:07.487133+00:00","generated_at":"2026-08-12T20:09:30.605084+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OptimizeRx Q2 revenue falls 30% to $20.5M, swings to GAAP net loss; reaffirms FY guidance","bullets":["Q2 revenue $20.5M, down 30% YoY from $29.2M; GAAP net loss $(0.7)M or $(0.04)/share vs $1.5M net income ($0.08) in Q2 2025.","Non-GAAP net income $3.1M ($0.16 diluted) vs $3.7M ($0.19) prior year; adjusted EBITDA $4.9M vs $5.8M.","FY2026 guidance reaffirmed: revenue $95-100M and adjusted EBITDA $21-25M.","CFO Ed Stelmakh steps down Dec 31, 2026; Andy D'Silva becomes CFO and Heather Favazza CAO effective Jan 1, 2027.","Stelmakh gets 12 months base salary ($450K/yr), $247.5K bonus lump sum, COBRA; advisory role through Dec 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001448431-26-000014","json":"https://secwatch.observer/filing/0001448431-26-000014.json","markdown":"https://secwatch.observer/filing/0001448431-26-000014.md","text":"https://secwatch.observer/filing/0001448431-26-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/0001448431-26-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/oprx-20260807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T20:09:30.605084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}